Nizar J. Bahlis, Saad Z. Usmani, Thierry Facon, Sonja Zweegman, Christopher P. Venner, Marc Justin Braunstein, Ludek Pour, Josep Marti, Supratik Basu, Yael C. Cohen, Morio Matsumoto, Kenshi Suzuki, Cyrille Hulin, Sebastian Grosicki, Wojciech Legiec, Angelo Maiolino, Mai Ngo, Maria Krevvata, Melissa Rowe, Vania Hungria. "Daratumumab + bortezomib, lenalidomide, and dexamethasone (DVRd) vs VRd in transplant-ineligible (TIE)/transplant-deferred (TD) newly diagnosed multiple myeloma (NDMM): Phase 3 CEPHEUS trial cytogenetic subgroup analysis.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.7529